EICHOR
● Active Not Recruiting
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
Condition: Non-Transfusion-dependent Alpha-Thalassemia · Non-Transfusion-dependent Beta-Thalassemia · Sponsor: Agios Pharmaceuticals, Inc.
About this study
The primary purpose of this study was to compare the effect of mitapivat versus placebo on hemolytic anemia in participants with alpha- or beta-non-transfusion dependent thalassemia (NTDT).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (68)
| San Diego Hospital, UC San Diego Health | La Jolla, California, United States | — |
| Stanford Medicine | Palo Alto, California, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| Weill Cornell Medical Center | New York, New York, United States | — |
| Duke University Medical Center | Durham, North Carolina, United States | — |
| Penn Medicine - University of Pennsylvania Health System | Philadelphia, Pennsylvania, United States | — |
| Universidade de Caxias do Sul | Caxias do Sul, Brazil | — |
| Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP | Ribeirão Preto, Brazil | — |
| HEMORIO Instituto Nacional de Hematologia | Rio de Janeiro, Brazil | — |
| Praxis Pesquisa Medica | Santo André, Brazil | — |
| GSH Banco de Sangue de São Paulo | São Paulo, Brazil | — |
| Instituto do Cancer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidad de São Paulo | São Paulo, Brazil | — |
+ 56 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.